Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
3.620
-0.020 (-0.55%)
Dec 18, 2025, 9:55 AM EST - Market open
Erasca Market Cap
Erasca has a market cap or net worth of $1.03 billion as of December 18, 2025. Its market cap has increased by 12.46% in one year.
Market Cap
1.03B
Enterprise Value
718.62M
1-Year Change
12.46%
Ranking
Category
Stock Price
$3.62
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $1.03B, a decrease of -44.73%. That is a compound annual growth rate of -12.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 1.03B | 45.52% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 949.74B |
| Johnson & Johnson | 515.69B |
| AbbVie | 401.20B |
| UnitedHealth Group | 308.73B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 246.49B |
| Novo Nordisk | 224.22B |